Ann: Natshield to be trialled by intelligent sterilisation robots, page-177

in a very short space of time they have established distribution relationships either for Natshield itself or for inclusion in other products with
1) health therapies US
2) OOH- medical UK (pending actual inking the deal and communicating it
3) Skin Therapies SKN
4) eight mercatus

we will see more deals and distributors in coming months in new geographies. I wouldn’t be surprised to see the numbers of partners / buyers / products hit double figures within 3 months.

it’s actually a pretty smart way to commercialise a ‘platform’ technology and let others with different corporate strengths and relationships

the two questions I would really like to see some comment or insight on in the future are
1) what is the production capacity (or constraints if any) of pathaway itself in raw ingredient form to supply wholesale for uses such as misting (as opposed to bottling plants for sanitizer which have different additional constraints)
2) what margin they make on Natshield both in wholesale bulk and in consumer products

may only get a sense on these really though in the numbers in the next 2/3/4 coming qtrly reports